Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-033944
Filing Date
2024-02-13
Accepted
2024-02-13 17:11:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d712930dsc13g.htm SC 13G 39869
  Complete submission text file 0001193125-24-033944.txt   41160
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Subject) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93617 | Film No.: 24629179
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 171 FOREST LN. MENLO PARK CA 94025
Business Address
Easom Eric (Filed by) CIK: 0001914503 (see all company filings)

Type: SC 13G